Dr. Jingjing Yu will be contributing to the Inaugural Asian DDI Conference scientific program (December 3-6, 2018 – Hong Kong) with a presentation entitled “Mechanistic Analysis of the Risk of Pharmacokinetic Drug-Drug Interactions with Drugs Recently Approved by the US Food and Drug Administration“.
Category: Events
DIDB Team at the 18th International Conference on Drug-Drug Interactions
The DIDB team will be exhibiting at the upcoming 18th International Conference on Drug-Drug Interactions in Seattle on June 29-July 1, 2014, and will contribute to the scientific program with two presentations:
* Critical Review of the 2014-2015 Literature (Dr. Sophie Argon)
* New Molecular Entities Approved by FDA in 2014: Review of In Vitro and In Vivo Data (Dr. Jingjing Yu)
Dr. Ragueneau-Majlessi will be chairing the session entitled “NDA and Literature Update” on June 29th.
DIDB Team at the 17th International Conference on Drug-Drug Interactions
The DIDB team will be exhibiting at the 17th International Conference on Drug-Drug Interactions in Seattle on June 30-July 2, 2014, and will contribute to the scientific program with two presentations:
* Critical Review of the 2013-2014 Literature (Dr. Sophie Argon)
* New Molecular Entities Approved by FDA in 2013: Review of In Vitro and In Vivo Data (Dr. Jingjing Yu)
Dr. Ragueneau-Majlessi will be chairing the session entitled “NDA and Literature Update” on June 30th.